CN100590119C - Antineoplastic compound of red pineapple flower alkali A, preparation method and application thereof - Google Patents
Antineoplastic compound of red pineapple flower alkali A, preparation method and application thereof Download PDFInfo
- Publication number
- CN100590119C CN100590119C CN200810034539A CN200810034539A CN100590119C CN 100590119 C CN100590119 C CN 100590119C CN 200810034539 A CN200810034539 A CN 200810034539A CN 200810034539 A CN200810034539 A CN 200810034539A CN 100590119 C CN100590119 C CN 100590119C
- Authority
- CN
- China
- Prior art keywords
- pineapple flower
- compound
- red pineapple
- red
- flower alkali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention pertains to the medical technology, in particular to an anti-tumor compound of incarvillea delavayi base A. The compound is a new alkaloid compound, which is extracted from the Chinese herbal medicine incarvillea delavayi. The precise mass number of the compound is 278.1546 (M plus H) <plus>, the molecular formula is C19H19NO by calculation; and the ultraviolet spectrum has strong absorption at 273nm and 249nm. Experiments show that the compound has good activity for inhibiting various tumor cells and can be used for the preparation of anti-tumor drugs.
Description
Technical field
The invention belongs to medical technical field, be specifically related to a kind of new anti-tumor biological bases compound of red pineapple flower alkali A (Delavatine A) that separation obtains from the plant red pineapple flower and its production and application.
Background technology
Tumour is to cause one of human main causes of death.Ministry of Health of China is announced urban and rural residents' major causes of death in 2006 a few days ago.Statistics shows that malignant tumour has become the primary cause of the death.As seen the prevention of tumour and treatment are very urgent.Pharmacological agent is one of main treatment means of tumour.At present, though developed tens kinds of antitumor drugs, effectively prolonged patient's life or improved patient's life quality.Some anti-tumor drugs treatment curative effect highly significant wherein is as the pharmacological agent acute leukemia of children etc.But the drug research of tumour and exploitation also face huge challenge, mostly are cell toxicity medicament as antitumor drug, and its side effect is obvious, has limited the performance of these curative effect of medication.Famous tumor aetiology man, member of Chinese Academy of Engineering's journey book an ancient unit of weight are thought: current medical science still is in the junior stage for the control of tumour.Chinese medicine has the basis of human toxicity experiment in several thousand, and perhaps Chinese medicine can be walked prostatitis in the world at anti-tumor aspect.The lead compound of seeking the anti-tumor activity of high-efficiency low-toxicity from natural product is the focus of new drug research always.
The purple section Chinese Incarvilla Herb platymiscium Incarvillea L. whole world of rivering bend has 14 kinds, China has 10 kinds, be distributed in the southwest more, areas such as northeast, North China, northwest in addition, wherein 5 kinds (Chinese Incarvilla Herb, Westerner's grass, red pineapple flower, Root of Delavay Incarvillea is hidden the POLO flower) hyoscine, in treatment hepatitis, the bacillary dysentery etc. of being mainly used among the people.The research of diagonal angle artemisia is less, and jade is bright late since nineteen ninety waits the people that Chinese Incarvilla Herb I.sinensis Lam. and Westerner's grass I.arguta (Royle) Royle have been carried out the research of chemical ingredients and pharmacologically active.Red pineapple flower (Incarvillea delavay) is that the Bignoniaceae Chinese Incarvilla Herb belongs to (Incarvillea L) plant, and perennial acaulescence draft mainly is distributed in Yunnan and Sichuan.The root of red pineapple flower is used as medicine as Root of Delavay Incarvillea.It is sweet, light, warm in nature to distinguish the flavor of.Invigorating qi and benefiting blood.Cure mainly insufficiency of vital energy and blood after being ill, dizziness and fatigue, postpartum few breast (" China's book on Chinese herbal medicine " editorial committee, " China's book on Chinese herbal medicine ", the .1999 of Shanghai science tech publishing house, the 7th fascicle, 426-427).
Separate from medicinal plant at present that to have antineoplastic activeconstituents be one of focus of chemist.And at present few to the chemical constitution study of red pineapple flower, so we have carried out the chemical constitution study of system to red pineapple flower, in the hope of from wherein separating the natural product that obtains having good antineoplastic activity.
Summary of the invention
The object of the present invention is to provide a kind of natural compounds and its production and application with good resistance tumor effect.
The present invention is a kind of new alkaloid compound that extraction separation obtains from the red pineapple flower that is grown in the Chinese yunnan Eryuan County, called after Delavatine A, and its chemical structural formula is as follows:
The preparation method of above-claimed cpd is as follows:
(1) extracts: the dry herb of red pineapple flower, pulverize, with 80% alcohol reflux 2-4 time, each 1.5-2.5 hour, the extracting solution concentrating under reduced pressure became medicinal extract, transfer Ph to 2-3 with HCl solution behind the thin up, filter, get filtrate and filter residue, filtrate adds NaOH solution and transfers Ph to 10-11, use chloroform extraction, obtain chloroform extract;
(2) separate: above-mentioned chloroform extract applying silicon plastic column chromatography, it with volume chloroform-acetone system gradient elution of 20: 1~2: 1, thin-layer chromatography detects, collection contains the flow point of red pineapple flower alkali A, again through the C18 reversed phase column chromatography, with weight ratio is 50: 100-70: 100 methanol-water carries out wash-out, and thin-layer chromatography detects, and gets the pure product of red pineapple flower alkali A.
Alkaloid compound DelavatineA of the present invention is a yellow oil, [α]
20 D+ 56 ° (c 0.05, CH
3Cl); The bismuth potassium iodide reacting positive; By electron spray(ES) ion massspectrum signal m/z 278[M+H]
+, high resolution mass spectrum must the accurate total mass number of this compound is 278.1546[M+H]
+, calculate that its molecular formula is C
19H
19NO; UV spectrum has strong absorption at 273nm and 249nm.
1H and
13The C nuclear magnetic resonance data sees Table 1.
Experiment shows that this compound thing has good inhibition activity to kinds of tumor cells, can be used for preparing antitumor drug.
Table 1Delavatine A's
1H and
13The C nuclear magnetic resonance data
13C?and?
1H?δppm?recorded?at?600MHz
J: coupling constant
Embodiment
The following examples can make those skilled in the art more fully understand the present invention, but do not limit the present invention in any way.
Embodiment 1:
Red pineapple flower (Incarvillea delavay) herb 3kg, with 80% ethanol 20L refluxing extraction 3 times, each 2 hours, united extraction liquid, concentrating under reduced pressure gets 60g medicinal extract, use 2%HCl behind the thin up, transfer PH to 2-3, filter, get filtrate and filter residue, filtrate adds 20%NaOH and transfers PH to 11, uses chloroform extraction, obtains chloroform extract; Concentrating under reduced pressure extraction position obtains crude product 25g.Crude product mixed with 50g silica gel mix sample, be added to the silicagel column top that has installed, with chloroform-acetone (volume ratio is 20: 1~2: 1) system's gradient elution, collection contains the flow point of Delavatine A, again through the C18 reversed phase column chromatography, carry out wash-out with methanol-water (weight ratio is 50%-70%), thin-layer chromatography detects, and gets the pure product 212mg of Delavatine A.
The cytotoxic activity experiment of embodiment 2:Delavatine A
1, experiment material
1.1, given the test agent
After Delavatine A dissolves with DMSO (Merck), add solution or uniform suspension that PBS (-) is made into 1000 μ g/ml, then with PBS (-) dilution that contains DMSO.
1.2, cell strain
A549 (human lung carcinoma cell)
LOVO (people's colon-cancer cell)
6T-CEM (human T cell leukemia cell)
HL-60 (human leukemia cell)
HepG-2 (human liver cancer cell)
1.3, nutrient solution
RPMI1640+15%NBS+ is two anti-
1.4, other materials
Full-automatic microplate reader: model: WellscanMK-2, production firm: Labsystems
Import 96 well culture plates etc.
2, test method
Mtt assay: it is 4~6 * 10 that the every hole of 96 orifice plates adds concentration
4The cell suspension 100 μ l of individual/ml put 37 ℃, 5%CO
2In the incubator.Behind the 24h, add sample liquid, two multiple holes are established in 10 μ l/ holes, and 37 ℃, 5%CO
2Effect 72h.Every hole adds the MTT solution 20 μ l of 5mg/ml, adds lysate behind the effect 4h, and put in the incubator in 100 μ l/ holes, and 570nm OD value is surveyed with the full-automatic microplate reader of MK-2 in the dissolving back.
3, test-results
The results are shown in Table 2, the result shows that Delavatine A is to human lung carcinoma cell, people's colon-cancer cell, the human T cell leukemia cell, human leukemia cell and human liver cancer cell all have better inhibited activity, Delavatine A has favorable anti-tumor effect, has the excellent development prospect.
Embodiment 3:DelavatineA is to the efficacy experiment of mouse S180 sarcoma (solid-type)
1, experiment material
1.1 given the test agent
Delavatine A uses the 0.5%CMC wiring solution-forming after with a small amount of tween-80 hydrotropy.
1.2 animal
Strain: Kunming mouse
The source: the The 2nd Army Medical College Experimental Animal Center provides.
Conformity certification number: Shanghai is moving closes the card word No. 107
Body weight: 18-20g
Sex: female.
1.3 transplanted tumor
Mouse S180 sarcoma is gone down to posterity by Shanghai Institute of Pharmaceutical Industry and to keep.
2, experimental technique
Get well-grown mouse S180 sarcoma ascites, dilute with 1: 4 with physiological saline, every mouse armpit subcutaneous vaccination 0.2ml, random packet is divided into control group, endoxan group (CTX group, 20mg/kg, ip * 7), LID-15-1 (5mg/kg) group, next day is played administration in the inoculation back, the administration volume is the 0.5ml/20g body weight, continuous irrigation stomach 7 days.Inoculate back 10 days and take off neck execution animal, dissect behind the title the weight of animals and get the knurl piece, claim knurl heavy.The result judges according to following formula:
3, experimental result
Delavatine A has significant tumor-inhibiting action.Experimental result sees Table 3.
Table 2Delavatine A is to the in-vitro multiplication restraining effect of human body tumour cell
Table 3DelavtineA is to the restraining effect of mouse S180 sarcoma
Compare with control group: * P<0.05, * * P<0.01.
Claims (3)
1, a kind of antineoplastic compound of red pineapple flower alkali A is characterized in that chemical structural formula is as follows:
2, the preparation method of antineoplastic compound of red pineapple flower alkali A as claimed in claim 1 is characterized in that concrete steps are as follows:
(1) extracts: the dry herb of red pineapple flower, pulverize, with 80% alcohol reflux 2-4 time, each 1.5-2.5 hour, the extracting solution concentrating under reduced pressure became medicinal extract, transfer pH to 2-3 with HCl solution behind the thin up, filter, get filtrate and filter residue, filtrate adds NaOH solution and transfers pH to 10-11, use chloroform extraction, obtain the chloroform part;
(2) separate: above-mentioned chloroform certain applications silica gel column chromatography, it with volume ratio chloroform-acetone system gradient elution of 20: 1~2: 1, thin-layer chromatography detects, collection contains stream part of red pineapple flower alkali A, again through the C18 reversed phase column chromatography, with weight ratio is 50: 100-70: 100 methanol-water carries out wash-out, and thin-layer chromatography detects, and gets the pure product of red pineapple flower alkali A.
3, the application of antineoplastic compound of red pineapple flower alkali A according to claim 1 in the preparation antitumor drug.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810034539A CN100590119C (en) | 2008-03-13 | 2008-03-13 | Antineoplastic compound of red pineapple flower alkali A, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810034539A CN100590119C (en) | 2008-03-13 | 2008-03-13 | Antineoplastic compound of red pineapple flower alkali A, preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101245048A CN101245048A (en) | 2008-08-20 |
CN100590119C true CN100590119C (en) | 2010-02-17 |
Family
ID=39945760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810034539A Expired - Fee Related CN100590119C (en) | 2008-03-13 | 2008-03-13 | Antineoplastic compound of red pineapple flower alkali A, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100590119C (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008468B (en) * | 2010-11-26 | 2012-11-21 | 中国人民解放军第二军医大学 | Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases |
CN103288732A (en) * | 2012-02-27 | 2013-09-11 | 上海壹志医药科技有限公司 | Salts of incarvillea delavayi base A derivatives |
CN108159045B (en) * | 2018-02-28 | 2019-12-10 | 中国人民解放军第二军医大学 | application of robinine A and derivatives thereof in preparation of medicines for preventing or treating central nervous system diseases |
-
2008
- 2008-03-13 CN CN200810034539A patent/CN100590119C/en not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
A new iridoid from Incarvillea delavayi. Tao Lu et al.Chinese Chemical Letters,Vol.18 . 2007 |
A new iridoid from Incarvillea delavayi. Tao Lu et al.Chinese Chemical Letters,Vol.18. 2007 * |
Also Published As
Publication number | Publication date |
---|---|
CN101245048A (en) | 2008-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103316096A (en) | General flavone extract of seeds of nigella damascena l., nigella sativa l. or nigella glandulifera freyn et sint., and preparation method and use thereof | |
CN102133255B (en) | Antineoplastic podophyllum traditional Chinese medicine extract and preparation method and application thereof | |
CN101824014B (en) | Compounds with anti-tumor activity in chloranthus japonicus and purpose thereof | |
CN101444500A (en) | Application of iridoid in preparing anti-tumor medicine | |
CN100590119C (en) | Antineoplastic compound of red pineapple flower alkali A, preparation method and application thereof | |
CN102030800B (en) | Abies holophylla triterpenoid compound, extraction separation thereof and application thereof | |
CN105859805A (en) | Preparation method and application of novel phenolic glycoside compound extracted from green peel of Juglans mandshurica Maxim | |
CN105037464A (en) | Plant flavone compounds, and preparation method and application thereof | |
CN102021137A (en) | Method for preparing glycyrrhiza total flavonoids from glycyrrhiza hairy roots and culture solution thereof | |
CN101284835B (en) | Dimeric sesquiterpene lactone compounds, preparation method and applications thereof | |
CN101565443B (en) | New fir triterpene lactone compound, preparation method and application thereof | |
CN101229212A (en) | Lonicera fulvotnetosa total secondary saponin position, preparing method and antitumor uses thereof | |
CN101318946B (en) | Dimeric ainsliaea terpene A, preparation and application thereof | |
CN110105210A (en) | Thymol derivative and its preparation method and application | |
CN100584837C (en) | Hydroxy stilbene kind compound and its preparation method and application | |
CN101721434B (en) | Active ingredients of fomes officinalis, preparation method thereof and use thereof | |
CN101982171B (en) | Application of fenugreek biflavone glycosides for preparing anti-virus or/and anti-tumor drugs | |
CN101444501A (en) | Application of mother-nucleus conjugated iridoid in preparing anti-tumor medicine | |
CN101284004B (en) | Application of two bi-sesquiterpenes compound for preparing antineoplastic and antiinflammatory medicine | |
CN105801634A (en) | Preparation method and application of new straight chain alcohol and glucoside compound in walnut green husks | |
CN100594900C (en) | Application of alkaloid compounds in preparing antineoplastic medicaments | |
CN101284834B (en) | Bi-inulicin 1, preparation method and applications thereof | |
CN104688798A (en) | Gypsophila oldhamiana Miq extractive preparation method and application | |
CN101318966B (en) | Dimerized sesquiterpenoids, preparation and application thereof | |
CN101284833B (en) | Compound bi-inulicin 4, preparation method and applications thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100217 Termination date: 20160313 |